Tandem Diabetes Shows Strong Investor Demand with $275 Million Pricing Adjustment

Photo of author
Written By Marcus Reynolds

Tandem Diabetes Care, Inc., a leading global insulin delivery and diabetes technology company, has declared the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (referred to as the “notes”) in a private placement aimed at qualified institutional buyers. 

The offering, originally set at $250.0 million, has been upsized, showcasing strong investor demand. 

Additionally, Tandem has granted the initial purchasers an option to acquire up to an additional $41.25 million aggregate principal amount of notes.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. is a leading global insulin delivery and diabetes technology company headquartered in San Diego, California. 

Credits: DepositPhotos

The company is dedicated to manufacturing and selling advanced automated insulin delivery systems, including the Tandem Mobi system and the t:slim X2 insulin pump, both incorporating Control-IQ advanced hybrid closed-loop technology. 

These innovations aim to alleviate the burden of diabetes management and open new possibilities for patients, caregivers, and healthcare providers.

Read More: Sibanye-Stillwater Explores Further Cost-Cutting Measures Amidst Challenging Market Conditions

Details of Convertible Senior Notes

The notes, which will be general unsecured obligations of Tandem, will carry a semiannual interest payable on March 15 and September 15 of each year, commencing September 15, 2024, at a rate of 1.50% per annum. 

The maturity date for these notes is March 15, 2029, unless earlier converted, redeemed, or repurchased.

Utilization of Proceeds

Proceeds from the offering, estimated to be approximately $266.3 million (or roughly $306.4 million if the initial purchasers exercise their option in full), will be utilized for various purposes. 

Also Read: Minim, Inc. Faces Nasdaq Listing Deficiency Notice

Conversion and Redemption Terms

These include covering the cost of capped call transactions, repurchasing a portion of its 1.50% Convertible Senior Notes due 2025 (2025 notes), and repurchasing common stock through privately negotiated transactions. 

In the event of the initial purchasers exercising their option, the remainder of the proceeds will be allocated for general corporate purposes.

Notably, holders have the right to convert their notes under specific conditions before December 15, 2028, with a conversion rate initially set at 28.9361 shares of Tandem’s common stock per $1,000 principal amount of notes, equivalent to an initial conversion price of approximately $34.56 per share. 

Tandem is restricted from redeeming the notes before March 22, 2027, but may opt to redeem them afterward under certain conditions.

Capped Call Transactions 

To mitigate dilution to its common stock resulting from any conversion of the notes, Tandem has entered into capped call transactions. 

Additionally, Tandem anticipates hedging activities by option counterparties, which may impact the market price of its common stock and the notes.

Repurchasing of Notes 

Concurrently with the notes offering, Tandem has entered into privately negotiated transactions to repurchase approximately $246.7 million aggregate principal amount of its 2025 notes, further reinforcing its financial strategy.

Impact on Tandem’s Stock

Credits: DepositPhotos

Investors should note that the notes and any shares of Tandem’s common stock issued upon conversion have not been registered under the Securities Act or any state securities laws. 

Read Next: Is Upwork Stock Worth a Closer Look in 2024?


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of SmallCapStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: www.SmallCapStocks.com/Disclaimer and www.SmallCapStocks.com/Privacy-Policy

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.